Literature DB >> 2167729

Intravitreal therapy with ganciclovir for posterior pole cytomegalovirus retinitis in AIDS patients.

J Orellana, R M Lieberman, R Peairs, S Restreppo.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2167729      PMCID: PMC1042191          DOI: 10.1136/bjo.74.8.511-b

Source DB:  PubMed          Journal:  Br J Ophthalmol        ISSN: 0007-1161            Impact factor:   4.638


× No keyword cloud information.
  5 in total

1.  Intravitreal ganciclovir in CMV retinitis: case report.

Authors:  M L Harris; M B Mathalone
Journal:  Br J Ophthalmol       Date:  1989-05       Impact factor: 4.638

2.  Long-term intravitreal ganciclovir for cytomegalovirus retinitis in a patient with AIDS. Case report.

Authors:  E R Büchi; P L Fitting; A E Michel
Journal:  Arch Ophthalmol       Date:  1988-10

3.  Use of intravitreal ganciclovir (dihydroxy propoxymethyl guanine) for cytomegalovirus retinitis in a patient with AIDS.

Authors:  K Henry; H Cantrill; C Fletcher; B J Chinnock; H H Balfour
Journal:  Am J Ophthalmol       Date:  1987-01-15       Impact factor: 5.258

4.  Intravitreal ganciclovir in the treatment of AIDS-associated cytomegalovirus retinitis.

Authors:  F M Ussery; S R Gibson; R H Conklin; D F Piot; E W Stool; A J Conklin
Journal:  Ophthalmology       Date:  1988-05       Impact factor: 12.079

5.  Treatment of cytomegalovirus retinitis with intravitreal ganciclovir. Long-term results.

Authors:  H L Cantrill; K Henry; N H Melroe; W H Knobloch; R C Ramsay; H H Balfour
Journal:  Ophthalmology       Date:  1989-03       Impact factor: 12.079

  5 in total
  2 in total

Review 1.  Ocular complications of the acquired immunodeficiency syndrome. Focus on the treatment of cytomegalovirus retinitis with ganciclovir and foscarnet.

Authors:  W J Keijer; D M Burger; G H Neuteboom; J L Vrooland; P L Meenhorst; C H Koks; J H Beijnen
Journal:  Pharm World Sci       Date:  1993-04-23

Review 2.  Ganciclovir. An update of its therapeutic use in cytomegalovirus infection.

Authors:  A Markham; D Faulds
Journal:  Drugs       Date:  1994-09       Impact factor: 9.546

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.